Audrey Mauguen

4.8k total citations
111 papers, 2.1k citations indexed

About

Audrey Mauguen is a scholar working on Oncology, Cancer Research and Neurology. According to data from OpenAlex, Audrey Mauguen has authored 111 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 23 papers in Cancer Research and 22 papers in Neurology. Recurrent topics in Audrey Mauguen's work include Neuroblastoma Research and Treatments (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Audrey Mauguen is often cited by papers focused on Neuroblastoma Research and Treatments (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Audrey Mauguen collaborates with scholars based in United States, France and Germany. Audrey Mauguen's co-authors include Marie‐Cécile Le Deley, Farid Boulad, Jean‐Pierre Pignon, Heiko Schöder, Andrew L. Kung, Benjamin Besse, Nancy Bouvier, Mini Kamboj, Domnita-Ileana Burcoveanu and M. Fukuoka and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Journal of the American Statistical Association.

In The Last Decade

Audrey Mauguen

103 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Mauguen United States	27	785	509	406	394	321	111	2.1k
Mohammad K. Khan United States	30	1.0k 1.3×	970 1.9×	432 1.1×	223 0.6×	172 0.5×	121	2.5k
Carlo Tondini Italy	28	1.2k 1.5×	476 0.9×	363 0.9×	551 1.4×	567 1.8×	104	2.3k
Gwénaël Le Teuff France	25	918 1.2×	1.2k 2.3×	677 1.7×	199 0.5×	581 1.8×	97	2.7k
Noah Federman United States	28	1.0k 1.3×	1.3k 2.6×	845 2.1×	334 0.8×	332 1.0×	142	3.0k
Stefano Maria Magrini Italy	27	748 1.0×	1.4k 2.8×	295 0.7×	369 0.9×	331 1.0×	163	2.7k
Stefania Croci Italy	27	518 0.7×	835 1.6×	733 1.8×	126 0.3×	216 0.7×	109	2.4k
Henry G. Kaplan United States	22	831 1.1×	325 0.6×	233 0.6×	337 0.9×	396 1.2×	79	1.6k
David Shultz Canada	24	547 0.7×	899 1.8×	356 0.9×	263 0.7×	160 0.5×	136	2.1k
Fariba Navid United States	31	896 1.1×	1.3k 2.6×	686 1.7×	351 0.9×	298 0.9×	104	2.8k
Alex McMillan United States	33	944 1.2×	712 1.4×	861 2.1×	542 1.4×	716 2.2×	57	3.5k

Countries citing papers authored by Audrey Mauguen

Since Specialization

Citations

This map shows the geographic impact of Audrey Mauguen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Mauguen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Mauguen more than expected).

Fields of papers citing papers by Audrey Mauguen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Mauguen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Mauguen. The network helps show where Audrey Mauguen may publish in the future.

Co-authorship network of co-authors of Audrey Mauguen

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Mauguen. A scholar is included among the top collaborators of Audrey Mauguen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Mauguen. Audrey Mauguen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kushner, Brian H., Shakeel Modak, Audrey Mauguen, et al.. (2025). A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission. Clinical Cancer Research. 31(10). 1877–1884. 1 indexed citations

Mauguen, Audrey, Farid Boulad, Maria Cancio, et al.. (2024). Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients. Cytotherapy. 26(4). 351–359. 4 indexed citations

Lavery, Jessica A., et al.. (2024). Safety and tolerability of intravenous aprepitant and fosaprepitant in children with cancer: A retrospective, single‐center review. Pediatric Blood & Cancer. 71(4). e30882–e30882.

Klein, Elizabeth, Audrey Mauguen, Jaap Jan Boelens, et al.. (2023). T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone Marrow Transplantation. 59(1). 23–33. 1 indexed citations

Pereira, Patrícia M. R., Komal Mandleywala, Sébastien Monette, et al.. (2022). Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nature Communications. 13(1). 2526–2526. 27 indexed citations

Mauguen, Audrey, Elizabeth Klein, Nancy A. Kernan, et al.. (2022). Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients. Cytotherapy. 24(4). 428–436. 8 indexed citations

Armstrong, Katherine, Audrey Mauguen, Emily K. Slotkin, et al.. (2022). Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention. Pediatric Blood & Cancer. 69(10). e29776–e29776. 3 indexed citations

Ogura, Koichi, Arielle Elkrief, Anita S. Bowman, et al.. (2022). Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. JCO Precision Oncology. 6(6). e2200048–e2200048. 6 indexed citations

Fraint, Ellen, Elizabeth Klein, Audrey Mauguen, et al.. (2022). Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(1). 46.e1–46.e6. 5 indexed citations

10.

Ibáñez, Glorymar, Audrey Mauguen, Néstor Rosales, et al.. (2021). Translational Strategies for Repotrectinib in Neuroblastoma. Molecular Cancer Therapeutics. 20(11). 2189–2197. 8 indexed citations

11.

Fabrizio, Vanessa A., Audrey Mauguen, Parastoo B. Dahi, et al.. (2021). Baseline Immune Status As a Corollary to Response to Adoptive Therapy with CMV or EBV CTLs. Transplantation and Cellular Therapy. 27(3). S344–S345. 1 indexed citations

12.

França, Paula Demétrio De Souza, Susanne Kossatz, Christian Brand, et al.. (2021). A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3618–3630. 33 indexed citations

13.

Mahajan, Sonia, Christopher A. Barker, Audrey Mauguen, et al.. (2021). ¹⁸F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma. Journal of Nuclear Medicine. 63(6). 906–911. 2 indexed citations

14.

Krebs, Simone, Audrey Mauguen, Onur Yıldırım, et al.. (2021). Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 3940–3950. 12 indexed citations

15.

Bailey, Kayleen, et al.. (2021). Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center. Pediatric Blood & Cancer. 69(7). e29539–e29539. 3 indexed citations

16.

Young, Robert J., Paula Demétrio De Souza França, Giacomo Pirovano, et al.. (2020). Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR. Neuro-Oncology Advances. 2(1). vdaa119–vdaa119. 26 indexed citations

17.

Francis, Jasmine H., et al.. (2020). Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS ONE. 15(7). e0235016–e0235016. 8 indexed citations

18.

Schöder, Heiko, Paula Demétrio De Souza França, Reiko Nakajima, et al.. (2020). Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer. Clinical Cancer Research. 26(13). 3110–3116. 48 indexed citations

19.

Kilday, John‐Paul, Caroline Domerg, Jennifer H. Ward, et al.. (2012). Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Société Française d'Oncologie Pédiatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clinical Cancer Research. 18(7). 2001–2011. 72 indexed citations

20.

Lamant, Laurence, Keith McCarthy, Emanuele S. G. d'Amore, et al.. (2011). Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study. Journal of Clinical Oncology. 29(35). 4669–4676. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact